期刊文献+

COX-2通过NF-κB通路上调胃癌细胞P-gp表达的实验研究 被引量:2

Experimental study of cyclooxygenase-2 up-regulates P-glycoprotein expression through NF-κB pathway on human gastric adenocarcinoma cell line SGC-7901
下载PDF
导出
摘要 目的探讨紫杉醇(TAX)作用下环氧化酶-2(COX-2)诱导胃癌细胞株SGC-7901多药耐药P蛋白(P-gp)表达可能的信号通路。方法 MTT法检测TAX、COX-2抑制剂NS-398和核因子-κB(NF-κB)信号通路抑制剂吡咯烷二硫代氨基甲酸盐(PDTC)不同剂量对胃腺癌细胞株SGC-7901生长的影响;Western blotting检测TAX作用于SGC-7901细胞株以及联合NS-398、PDTC对COX-2、NF-κB p65和P-gp表达的影响。结果 TAX、NS-398和PDTC均对胃癌细胞株SGC-7901的生长具有细胞毒作用,并呈剂量依赖性。TAX(0.1、0.3、0.5μmol/L)可诱导COX-2、p65和P-gp表达,随剂量增加,3种蛋白表达显著增加;与NS-398(5、10μmol/L)联用时,随剂量增加和时间延长,3种蛋白表达减少;与PDTC(0.2μmol/L)联用时,随作用时间延长,p65和P-gp表达减少。结论在TAX作用下,COX-2可能通过激活NF-κB通路而引起胃癌SGC-7901细胞株P-gp表达增加。 Objective To investigate the possible signal pathway of multi-drug resistant P-glycoprotein(P-gp)expression induced by cyclooxygenase-2(COX-2)in hunman gastric adenocarcinoma cell line SGC-7901 stimulating with pacliaxel(TAX).Methods The effects of TAX on SGC-7901 cells growth was assessed by MTT assay,and so did the effects of COX-2 selective inhibitor NS-398 and nuclear factor-κB(NF-κB) pathway inhibitor pyrrolidine dithiocarbamate(PDTC).The effect of a dose-ranging TAX and the change of combining NS-398 or PDTC with TAX on the COX-2,p65 and P-gp expression were detected by Western blotting.Results TAX,NS-398 and PDTC all had the effect of cellular toxicity on SGC-7901 cell line growth in a dose-dependent manner.When the dose of TAX(0.1,0.3,0.5μmol/L) increased,the expression of COX-2,p65 and P-gp showed rising trend in SGC-7901 cell line.And the expression of three proteins could decrease with the increase of dose and extension of time after combined with NS-398(5,10μmol/L).When combined with PDTC(0.2μmol/L),the expression of p65 and P-gp decreased significantly.Conclusion COX-2 may induce the expression of P-gp in SGC-7901 cell line via NF-κB pathway with the stimulation of TAX.
作者 陈玉 顾康生
出处 《临床肿瘤学杂志》 CAS 2012年第7期582-586,共5页 Chinese Clinical Oncology
关键词 环氧化酶-2 P-GP NF-ΚB 紫杉醇 胃腺癌SGC-7901细胞株 COX-2 P-gp NF-KB Paclitaxel Gastric adenocarcinoma cell line SGC-7901
  • 相关文献

参考文献14

  • 1Miller B, Patel VA, Sorokin A. Cyclooxygenase-2 rescues rat me- sangial cells from apoptosis induced by adriamycin via upregula- tion of multidrug resistance protein 1 (P-glycoprotein) [ J]. J Am Soc Nephrol, 2006,17 (4) : 977 - 985.
  • 2Nardone G, Rocco A, Vaira D,et al. Expression of Cox-2, mPGE- symhase|, MDR-1 ( P-gp ) , and Bcl-xL: a molecular pathway of Hpylori-related gastric carcineyenesis [ J ]. J Pathol, 2004,202 (3) :305 -312.
  • 3Pate1 VA, Dunn M J, Sorokin A. Regulation of MDR1 ( P-glycopro- rein) by cycloxygenase-2 [ J ]. J Biol Chem, 2002, 277 (41) : 38915 - 38920.
  • 4Zatelli MC, MolD, Tagliati F, et al. Cyclooxygenase-2 modulates chemoresistance in breast cancer cells involving NF-kappaB[ J]. Cell Oncol, 2009,31 (6) :457 -465.
  • 5Eichele K, Ramer R, Hinz B. Decisive role of cyclooxygenase-2 and lipocalin-type prostaglandin D synthase in chemothempeuties- induced apoptosis of human cervical carcinoma eells[ J ]. Onco- gene ,2008,27 ( 21 ) :3032 - 3044.
  • 6张梦曦,张林杰,顾康生.紫杉醇及塞来昔布对胃癌细胞株COX-2及P-gp表达的影响[J].临床肿瘤学杂志,2009,14(7):602-605. 被引量:2
  • 7Breier A,Barancik M,Sulovti Z, et al. P-glycoprotein implications of metabolism of neoplastic cells and cancer therapy [ J ]. Curr Cancer Drug Targets, 2005,5 ( 6 ) :457 - 468.
  • 8Zatelli MC, Luchin A, Taqliati F, et al. Cyclooxygenase-2 inhibi- tors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression, endocrine related [ J 1. Cancer,2007,14 (4) : 1029 - 1038.
  • 9Liu B, Qu L, Tao H. Cycloxygenase-2 up-regulates the effect of muhidrug resistance [ J ]. Cell Bio Lint,2009,34 ( 1 ) :21 - 25.
  • 10Yu L,Wu K, Li ZJ, et al. Enhancement of doxorubicin cytotoxici- ty on human esophageal squamous cell carcinoma cells by indom- ethacin and 4-[ 5-( 4-chloropbenyl )-3-( trifluoromethyl )-IH- pyrazol-l-yl ] benzenesulfonamide ( SC236 ) via inhibiting P-glyco- protein activity[J]. Mol Pharmacol,2009,75(6) :1364 -1373.

二级参考文献28

  • 1杨纯正,栾凤君,熊冬生,刘炳仁,许元富,顾孔书.阿霉素诱导的人白血病细胞系K562/A02多药抗药性(英文)[J].中国药理学报,1995,16(4):333-337. 被引量:23
  • 2Biedler JL, Riehm H. Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies. Cancer Res, 1970; 30 (4): 1174- 1184.
  • 3Garcia MG, Alaniz L, Lopes EC, et al. Inhibition of NF-kappaB activity by BAY11-7082 increases apoptosis in multidrug resistant leu- kemic T-cell lines. Leuk Res, 2005 ; 29(12) : 1425 - 1434.
  • 4Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell, 1986 ; 46(5) : 705 - 716.
  • 5Um JH, Kang CD, Lee BG, et al. Increased and correlated nuclear factor-kappa B and Ku autoantigen activities are associated with development of multidrug resistance. Oncogene, 2001 ; 20(42) : 6048 - 6056.
  • 6Garcia MG, Alaniz LD, Cordo Russo RI, et al. PI3K/Akt inhibition modulates multidrug resistance and activates NF-kappaB in murine lymphoma cell lines. Leuk Res, 2009; 33(2) : 288 -296.
  • 7Bentires-Alj M, Barbu V, Fillet M, et al. NF-kappaB transcription factor induces drug resistance through MDRI expression in cancer cells. Oncogene, 2003 ; 22 ( 1 ) : 90 - 97.
  • 8Tsuruo T, Iida H, Tsukagoshi S, et al. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res, 1981; 41(5) : 1967 -1972.
  • 9Guo F, Sun A, Wang W, et al. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells. Mol immunol, 2009; 46( 13): 2441 - 2448.
  • 10Sandur SK, Deorukhkar A, Pandey MK, et al. Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF-kappaB activity. Int J Radiat Oncol Biol Phys, 2009 ; 75 ( 2 ) : 534 - 542.

共引文献9

同被引文献5

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部